Peripheral Track

EPIC-SEC 2017

Emerging Therapies for PE, HOCM, & LAA Closure

Thursday, April 20
2:00 PM - 3:30 PM

Wissam A. Jaber

Emory University
Emory University

Wissam Jaber is an interventional cardiologist at Emory University Hospital Midtown.
He is the director of the complex coronary intervention program at Emory Heart Center, and the director of the pulmonary embolism response team at Emory University Hospital Midtown. He is involved in several research trials on invasive pulmonary embolism treatment.
He has done his medicine training at Duke University and cardiology at the Mayo Clinic, and has been in practice for 9 years.

Send Email for Wissam Jaber

Omar M. Lattouf

Professor
Emory University
Emory

Senior cardiothoracic surgeon, widely published and frequent speaker at national and international cardiology and cardiac surgery conferences on topics of Off-Pump Coronary Revascularization, Cardiac Resynchronization Therapy, Lesser Invasive Cardiac Disease Management, Left Ventricular Reduction Procedures, and Complex Valve Surgery.

Inventor with several patents in the field of minimally invasive and transapical heart technologies.

Dedicated to research, training and education, Lattouf serves on committees of, or teamed up with the American College of Cardiology, Emory University Halle Institute for Global Learning, Georgia Health Science University, the Georgia Department of Public Health and other national and international organizations to promote global cooperation to expand cardiovascular education, training and disease prevention.

Send Email for Omar Lattouf

Jacqueline Saw

Clinical Associate Professor
UBC
UBC

Dr. Saw is an Interventional Cardiologist at VGH, with joint appointment at St Paul’s Hospital. She is a Clinical Associate Professor of Medicine at UBC, and Program Director of the Interventional Cardiology Fellowship Program at VGH.

Dr. Saw’s research interests include spontaneous coronary artery dissection, antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral intervention, LAA closure, and non-atherosclerotic coronary artery disease including SCAD and coronary fibromuscular dysplasia. She is the principal investigator of the Canadian SCAD Study, PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG and ELAPSE studies.

Send Email for Jacqueline Saw

Henry A. Liberman

Physician
Emory Healthcare
Emory University

Dr. Liberman is Professor of Medicine (Cardiology) at Emory University School of Medicine and Director of the Cardiac Cath Lab and Interventional cardiology at Emory University Midtown. His main research interest are Acute Myocardial Infarction and Complex Coronary Intervention.

Send Email for Henry Liberman

Rohit Malhotra

Assistant Professor
University of Virginia
University of Virginia

Dr. Rohit Malhotra is an Assistant Professor in the Electrophysiology Section at the University of Virginia Health Sciences Center. He has been performing left atrial appendage closure for 2 years using the Watchman device, starting with the PREVAIL CAP study and has been performing AMULET implantation since 2016.

Send Email for Rohit Malhotra

Brent Keeling

Assistant Professor
Emory University

Dr. Brent Keeling is an assistant professor of surgery at Emory University in Atlanta, Georgia. His main clinical foci include treatment of complex aortic disease, coronary disease, and the treatment of pulmonary embolus. His research interests include a variety of clinical outcomes research projects using both local and national databases.

Send Email for Brent Keeling

James S. Jenkins

Associate Section Head Interventional Cardiology
Ochsner Medical Center
Ochsner Medical Center

Dr. Jenkins is a fellow of the American College of Cardiology, Society of Cardiac Angiography and Interventions and Society for Vascular Medicine and has been on staff at Ochsner since 1994. He is board certified in Cardiovascular Diseases, Internal Medicine, Interventional Cardiology and American Board of Vascular Medicine. He Specializes in Interventional Cardiology, including coronary and peripheral intervention, carotid stenting, percutaneous mitral, aortic, septal, LAA and venous intervention. He is the Director of Interventional Cardiology Research, an active clinical researcher and has written numerous articles and chapters for scientific medical publications.

Send Email for James Jenkins


Assets

Emerging Therapies for PE, HOCM, & LAA Closure



Attendees who have favorited this

Send Email for Emerging Therapies for PE, HOCM, & LAA Closure